Lōkahi Therapeutics
A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.
About
Technology stack
detected 2026-05-23No comments yet. Be the first to share your take.
What does Lōkahi Therapeutics do?
Lōkahi Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for debilitating neurological disorders. The company's lead candidate, LKT-144, is currently in Phase 2 trials for the treatment of amyotrophic lateral sclerosis (ALS). Lōkahi Therapeutics aims to address significant unmet medical needs in the neurology space through a combination of scientific rigor and strategic partnerships.
How much funding has Lōkahi Therapeutics raised?
Lōkahi Therapeutics has raised a total of $63M in funding. The most recent round on record is Series B.
Where is Lōkahi Therapeutics headquartered?
Lōkahi Therapeutics is headquartered in La Jolla, California, USA.
When was Lōkahi Therapeutics founded?
Lōkahi Therapeutics was founded in 2017.
What industry does Lōkahi Therapeutics operate in?
Lōkahi Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare, Neurology, Biotech, Drug Discovery.
How many employees does Lōkahi Therapeutics have?
Lōkahi Therapeutics has approximately 10 people on record.
What is Lōkahi Therapeutics's current status?
Lōkahi Therapeutics's current operating status is: Inactive.